Skip to content
PICO Portalanswers from OpenAlex

86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review

PaperCitations, authors & open-access status

86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review is a paper indexed in PICO Portal from OpenAlex.

How many citations does 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review have?

PICO Portalcitation count

86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review has 0 citations in the OpenAlex counts PICO Portal stores.

When was 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review published?

PICO Portalyear

86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review has 2025 year in the PICO Portal index.

What is the open-access status of 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review?

PICO Portaloa status

86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review has closed oa status in the PICO Portal index.

What is the DOI of 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review?

PICO Portaldoi

The DOI for 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review is on the source record.

What is the OpenAlex record for 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review?

PICO Portalopenalex

The OpenAlex for 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial